Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Vistagen Therapeutics (VTGN) Q2 2025 Earnings
VTGN
17
Jun
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.51
-0.46
-0.4
-0.35
Details
Expected EPS
-0.496667
Actual EPS
-0.43
Surprise EPS
0.07
Surprise Percent
+13.42%
Description
Vistagen Therapeutics (VTGN) has reported earnings of -0.43 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login